St. Jude Children's Research Hospital

Memphis, TN

Description

St. Jude Children’s Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children.

The St. Jude Brain Tumor Program is one of the largest clinical brain tumor programs in North America, with experts representing pediatric oncology, neuro-oncology, neurosurgery, radiation oncology, neuroradiology, neuro-pathology and neuropsychology. The team collaborates with world leading neuroscientists, cancer biologists and physicians from the St. Jude Neurobiology and Brain Tumor Program to advance understanding of the biology of normal and malignant growth in the nervous system. This knowledge is translated rapidly into Phase I, Phase II and Phase III therapeutic clinical trials for the most common and lethal forms of childhood brain tumors. Novel St. Jude brain tumor studies are currently ongoing in infant CNS tumors, medulloblastoma, malignant gliomas and localized, low-grade neoplasms. Additionally, the program has developed an active long-term follow-up effort that helps identify, treat and study the late sequelae of disease and treatment for childhood brain tumors.

Clinical trials for the brain tumor program at St. Jude are also developed in collaboration with other strong pediatric neuro-oncology programs, cooperative groups, the Children’s Oncology Group and the Pediatric Brain Tumor Consortium.

Housing Information

St. Jude provides safe, healthy, tranquil and family-oriented lodging for patient families who live more than 35 miles from the hospital when the patient’s treatment requires an overnight stay. Preserving a home-like family environment in one of the St. Jude-sponsored lodging facilities helps to reduce as much stress as possible during a difficult time.

Tri Delta Place – a short-term lodging facility for St. Jude patients and families who need lodging for 1-7 days.

Ronald McDonald House – a mid-term facility for St. Jude patients and families who need lodging for 8-90 days.

Target House - a long-term facility for St. Jude patients and families who need lodging for 90 days or more. For more information, please call 1-866-2ST-JUDE (1-866-278-5833) and ask for Patient Services.

For more information, please call 1-866-2ST-JUDE (1-866-278-5833) and ask for Patient Services

Contact information

 

Brain Tumor Program

St. Jude Children’s Research Hospital

262 Danny Thomas Place, MS 260

Memphis, TN 38105

Email: braintumors@stjude.org

Phone: 901-595-2544 or toll-free 1-866-278-5833, ext. 2544

Website: www.stjude.org/brain

Team

Principal Investigator
Pediatric Neuro-Oncologist
Dr. Gajjar is co-chair of the Department of Oncology, interim chair of the Department of Pediatric Medicine and director of the Neuro-Oncology Division at St. Jude Children’s Research Hospital. Dr. Gajjar is also co-leader of the hospital’s Neurobiology and Brain Tumor Program, one of five cross-disciplinary, multi-departmental programs in the St. Jude Comprehensive Cancer Center. He is principal or co-principal investigator in several innovative clinical trials of new treatments for a variety of childhood brain tumors, with a focus on medulloblastomas, PNET and rhabdoid tumors (ATRT). Dr. Gajjar has been instrumental in the growth of the Neuro-Oncology program at St. Jude and in developing international collaborations with Australia, Canada and other leading institutions in the United States. Dr. Gajjar also works to develop key bridges between the clinical research and laboratory-based research programs within the Neurobiology and Brain Tumor Program. Dr. Gajjar graduated from Grant Medical College, J.J. Group of Hospitals, Bombay, India. He completed research fellowships at the University of Oklahoma and University of South Florida. Dr. Gajjar completed his pediatric residency at USF’s All Children’s Hospital, where he was also chief resident. He is co-author of over 175 papers, many of which have contributed to the improved clinical care of children with brain tumors.
Co-Principal Investigator
Assistant Member, St. Jude Faculty
Dr. Christopher Tinkle is an Assistant Member in the Department of Radiation Oncology at St. Jude Children’s Research Hospital. Dr. Tinkle received his undergraduate degree at the University of Texas at Austin and completed MD/PhD training through the Tri-institutional MD/PhD program at Weill Cornell Medical College and Rockefeller University in the laboratory of Dr. Elaine Fuchs. He completed a translational internship at UT Southwestern Austin Programs and radiation oncology residency at the University of California San Francisco, where he developed an interest in pediatric brain tumors under the mentorship of Dr. Daphne Haas-Kogan. His translational research efforts are focused on the identification of novel molecular therapies targeting pediatric brain tumor-specific genomic alterations that enhance the therapeutic ratio of conventional DNA damaging agents.